|

Ovarian function suppression with endocrine treatments Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Gangnam Severance Hospital1

Indications

  • Premenopausal Breast Cancer1
  • Node-positive Breast Cancer1
  • Estrogen Receptor Positive Tumor1
  • HER2-negative Breast Cancer1
  • Breast Cancer1

Other1 trial

OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.